NCT02064504View on ClinicalTrials.gov

Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

February 19, 2014

Primary Completion Date

May 20, 2014

Study Completion Date

May 20, 2014

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK961081

Dry white to off white powder

DRUG

Fluticasone furoate

Dry white powder

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT02064504 - Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination | Biotech Hunter | Biotech Hunter